On the stock market since 2007, it operates in the world of health and science. It has 40 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Average growth of 9% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades 58% below its peak. The market has trimmed its expectations for the company.
There is $15.4M in the vault; even if every debt were paid off, $13.0M would remain.
A loss of $10.0M against $4.9M in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.50. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
At the current pace of spending, the cash lasts about 1.5 years. After that, the company needs to find new money.
On our five-subject report card, SPHRF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: SPHRF is a small company that closed last year at a loss. The road back to profit runs through spending discipline.